Puzo Michael J Abbott Laboratories Transaction History

Puzo Michael J

$339 Million
Q1 2025

A detailed history of Puzo Michael J transactions in Abbott Laboratories stock. As of the latest transaction made, Puzo Michael J holds 98,944 shares of ABT stock, worth $12.8 Million. This represents 3.87% of its overall portfolio holdings.

Number of Shares

98,944

Previous 98,569 0.38%

Holding current value

$12.8 Million

Previous $11.1 Million 17.71%

% of portfolio

3.87%

Previous 3.2%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	BUY	$111.1 - $140.22 $41,662 - $52,582	375 Added 0.38%	98,944 $13.1 Million
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $464,285 - $495,229	-4,148 Reduced 4.04%	98,569 $11.1 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $83,458 - $98,520	834 Added 0.82%	102,717 $11.7 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $199,546 - $222,743	1,981 Added 1.98%	101,883 $10.6 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $784,601 - $866,557	7,164 Added 7.72%	99,902 $11.4 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $201,394 - $246,523	2,233 Added 2.47%	92,738 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $186,952 - $224,311	1,957 Added 2.21%	90,505 $8.77 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $28,117 - $31,328	-279 Reduced 0.31%	88,548 $9.65 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $236,822 - $278,754	2,445 Added 2.83%	88,827 $8.99 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $35,837 - $42,043	377 Added 0.44%	86,382 $9.49 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $15,965 - $18,484	165 Added 0.19%	86,005 $8.32 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $19,393 - $23,440	-190 Reduced 0.22%	85,840 $9.33 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $37,968 - $46,300	333 Added 0.39%	86,030 $10.2 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $141,524 - $173,288	1,225 Added 1.45%	85,697 $12.1 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $30,331 - $33,555	-260 Reduced 0.31%	84,472 $9.98 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $293,355 - $345,321	-2,773 Reduced 3.17%	84,732 $9.82 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $123,642 - $145,669	-1,136 Reduced 1.28%	87,505 $10.5 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $89,775 - $97,829	-855 Reduced 0.96%	88,641 $9.71 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $144,607 - $175,615	-1,578 Reduced 1.73%	89,496 $9.74 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $99,464 - $127,302	-1,299 Reduced 1.41%	91,074 $8.33 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $16,772 - $24,526	267 Added 0.29%	92,373 $7.29 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $208,522 - $232,134	-2,656 Reduced 2.8%	92,106 $8 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $125,624 - $136,215	-1,535 Reduced 1.59%	94,762 $7.93 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $59,834 - $69,785	-821 Reduced 0.85%	96,297 $8.1 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $91,780 - $110,963	-1,386 Reduced 1.41%	97,118 $7.76 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $28,190 - $31,936	-430 Reduced 0.43%	98,504 $7.13 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $63,242 - $76,294	1,040 Added 1.06%	98,934 $7.26 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $107,252 - $118,375	1,863 Added 1.94%	97,894 $5.97 Million
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $174,718 - $197,540	3,105 Added 3.34%	96,031 $5.76 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $653,554 - $699,697	12,175 Added 15.08%	92,926 $5.3 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $3.88 Million - $4.33 Million	80,751	80,751 $4.31 Million

Others Institutions Holding ABT

# of Institutions

3,433

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $227B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account